Lonial, S
Durie, B
Palumbo, A
San-Miguel, J
Article History
Received: 31 March 2015
Revised: 21 July 2015
Accepted: 22 July 2015
First Online: 12 August 2015
Competing interests
: SL has acted as a consultant for Millennium, Celgene, Novartis, Bristol-Myers Squibb, Onyx and Sanofi. AP has acted as a consultant and received honoraria from Amgen, Bristol-Myers Squibb, Genmab A/S, Celgene, Janssen-Cilag, Millennium and Onyx. He has also received honoraria from Novartis and Sanofi. JSM has served on advisory committees for Millennium, Celgene, Novartis, Onyx, Janssen, Bristol-Myers Squibb, Merck Sharpe & Dohme and Sanofi. The remaining author declares no conflict of interest.